mianserin has been researched along with Phobic Disorders in 6 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of the present study was to investigate: (a) the incidence of social anxiety symptoms in inpatient alcoholics, (b) the effect of alcohol detoxification on these symptoms, and (c) whether a combined psychotherapeutic/mirtazapine treatment during the post-detoxification phase of alcoholism has a greater impact on the aforementioned symptoms than a non-pharmacological approach." | 5.10 | Alcohol detoxification and social anxiety symptoms: a preliminary study of the impact of mirtazapine administration. ( Christodoulou, G; Liappas, J; Paparrigopoulos, T; Tzavellas, E, 2003) |
| "Mirtazapine appears to be an effective agent in the treatment of social phobia in women and in the improvement of their health-related quality of life." | 2.71 | Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study. ( Anvar, J; Bachler, E; Egger, C; Fartacek, R; Kaplan, P; Kettler, C; Lahmann, C; Leiberich, PK; Loew, TH; Mitterlehner, F; Muehlbacher, M; Nickel, C; Nickel, MK; Pedrosa Gil, F; Rother, N; Rother, WK; Tritt, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanıdır, C | 1 |
| Hergüner, S | 1 |
| Schutters, SI | 1 |
| Van Megen, HJ | 1 |
| Van Veen, JF | 2 |
| Denys, DA | 1 |
| Westenberg, HG | 2 |
| Van Vliet, IM | 1 |
| Liappas, J | 1 |
| Paparrigopoulos, T | 1 |
| Tzavellas, E | 1 |
| Christodoulou, G | 1 |
| Muehlbacher, M | 1 |
| Nickel, MK | 1 |
| Nickel, C | 1 |
| Kettler, C | 1 |
| Lahmann, C | 1 |
| Pedrosa Gil, F | 1 |
| Leiberich, PK | 1 |
| Rother, N | 1 |
| Bachler, E | 1 |
| Fartacek, R | 1 |
| Kaplan, P | 1 |
| Tritt, K | 1 |
| Mitterlehner, F | 1 |
| Anvar, J | 1 |
| Rother, WK | 1 |
| Loew, TH | 1 |
| Egger, C | 1 |
| Mrakotsky, C | 1 |
| Masek, B | 1 |
| Biederman, J | 1 |
| Raches, D | 1 |
| Hsin, O | 1 |
| Forbes, P | 1 |
| de Moor, C | 1 |
| DeMaso, DR | 1 |
| Gonzalez-Heydrich, J | 1 |
5 trials available for mianserin and Phobic Disorders
| Article | Year |
|---|---|
Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Double-Blind Method; F | 2010 |
Mirtazapine in social anxiety disorder: a pilot study.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Humans; Male; Mianserin; Mirtazapine; Patient Dropo | 2002 |
Alcohol detoxification and social anxiety symptoms: a preliminary study of the impact of mirtazapine administration.
Topics: Adrenergic alpha-Antagonists; Adult; Alcoholism; Combined Modality Therapy; Female; Humans; Inactiva | 2003 |
Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Antidepressive Agents, Tricyclic; Double-Blind Method; Female; Health Status; Health Surveys; | 2005 |
Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia.
Topics: Adolescent; Age Factors; Antidepressive Agents, Tricyclic; Child; Dose-Response Relationship, Drug; | 2008 |
1 other study available for mianserin and Phobic Disorders
| Article | Year |
|---|---|
Mirtazapine for Choking Phobia: Report of a Pediatric Case.
Topics: Airway Obstruction; Antidepressive Agents, Tricyclic; Child; Female; Humans; Mianserin; Mirtazapine; | 2015 |